Aegis Lifesciences - Manufacturer & Exporter of all types of Haemostats

 

Welcome To Aegis Lifesciences

Establishment in 2008, in Ahmedabad (India), Aegis Lifesciences is one of the world’s leading manufacturer & exporter of all major types of Haemostats – made of Absorbable Gelatin, Oxidized Regenerated Cellulose (ORC) and medical grade PVA sponges.
It leads the industry with its own brand names – SURGISPON®, SURGI-ORC®, SURGI-PVATM & DENTOSPON®.

Aegis offers products across the globe, including the most quality-conscious markets like EU (European Union), NHS-UK, CIS, Central America, Russia, LATAM, MENA, South Africa, Southeast Asia regions, amongst others.

Not to mention, the base of its operations relies on international quality standards along with the state-of-the-art in-house manufacturing facilities. Aegis also enjoys the certification as ISO:13485, MDSAP and the GMP standards of many countries.

Aegis Lifesciences has gained international certificates of CE (Class III medical devices), MDSAP & ISO: 13485 Quality Assurance System from DNV, Norway.


More information: https://aegis-lifesciences.com/

Comments

Post a Comment

Popular posts from this blog

Comprehensive Health Check-Up: A Commitment to Employee Well-Being

Image
Introduction In today’s fast-paced work environment, the health of employees can often take a back seat to the pressures of meeting deadlines and maintaining productivity. However, maintaining a healthy workforce is crucial for fostering a positive work environment and ensuring long-term organizational success. Regular health check-ups at the office serve as an effective means to address this challenge, ensuring that employees have access to necessary health assessments without the need to disrupt their work routines. The positive impact of these initiatives not only improves employee well-being but also reinforces the company’s commitment to a healthier workforce. This blog will delve into why these check-ups are crucial and provide insights into how they can be effectively implemented in the workplace. Aegis Lifesciences Leads the Way in Workplace Wellness It’s often said that prevention is better than cure, a principle that Aegis Lifesciences upholds in its commitment to employee he
Read more

Role of Surgi-ORC® Fibril and SURGISPON® in Posterior Fossa Tumor Resections

Image
  In posterior fossa tumor resections, Surgi-ORC® Fibril and SURGISPON® play crucial roles in facilitating a successful surgery and promoting optimal patient outcomes. Here's how they contribute to the surgical process: Hemostasis : One of the primary roles of both Surgi-ORC® Fibril and SURGISPON® is to assist in achieving hemostasis, which is the control of bleeding during surgery. Posterior fossa tumor resections can involve intricate procedures near sensitive structures such as the brainstem and cranial nerves, where bleeding must be carefully managed to maintain a clear surgical field and prevent complications. Surgi-ORC® Fibril and SURGISPON® are applied to bleeding surfaces to promote clot formation and minimize bleeding, thus enhancing visibility and surgical precision. Tissue Protection : During posterior fossa tumor resections, it's essential to protect delicate neural tissues from damage during surgical manipulation. Surgi-ORC® Fibril and SURGISPON® act as physical ba
Read more

Revolutionizing Total Knee Arthroplasty: The Role of ORC in Bleeding Control

  Effective   bleeding control   remains a formidable challenge in   modern surgery , particularly in orthopedic procedures where managing bleeding from the exposed or cut surface of cancellous bone is a critical concern.   Total knee arthroplasty   (TKA), a prevalent surgery for severe knee arthritis within orthopedics, is notably associated with significant blood loss due to extensive bone cutting and exposure of a large surface area of cancellous bone [1]. Challenges in TKA: Patients undergoing primary TKA are particularly susceptible to significant intraoperative and postoperative blood loss, leading to potential complications such as pain, decreased range of motion, and delayed recovery. With an aging population and increased life expectancy, the annual incidence of TKA procedures is expected to rise, reaching an estimated 3 million in the United States by 2030 [2]. Role of Absorbable Haemostatic Agents: To address bleeding challenges in orthopedic surgeries, particularly in TKA,
Read more